HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GFAP in early multiple sclerosis: A biomarker for inflammation.

AbstractOBJECTIVE:
The role of Glial Fibrillic Acidic Protein (GFAP) as a potential biomarker for relapsing-remitting multiple sclerosis (RRMS) and clinically isolated syndrome (CIS) has been controversially discussed. The aim was to characterize the added value of GFAP levels in the CSF of RRMS and CIS patients in correlation with MRI lesion load.
MATERIALS & METHODS:
GFAP levels in the CSF from 18 patients with RRMS, 8 patients with CIS and 35 controls were analyzed together with MRI data for acute and chronic inflammatory lesion load.
RESULTS:
GFAP levels of patients vs. controls were higher (p=0.005), while there was no difference between GFAP levels in RRMS and CIS. There was no correlation between the number of supra- or infratentorial gadolinium enhancing lesions and GFAP levels, while there was a correlation between GFAP levels with infratentorial chronic inflammatory lesion load (p=0.0035). Most importantly, a highly significant correlation could be observed between GFAP levels and the intensity of gadolinium-enhancement as a parameter for the acute activity of inflammatory processes (p=0.0002).
CONCLUSIONS:
GFAP seems to be a useful biomarker for highly active acute inflammation in patients with RRMS as well as with CIS.
AuthorsRebecca Kassubek, Martin Gorges, Michael Schocke, Viktoria A M Hagenston, André Huss, Albert C Ludolph, Jan Kassubek, Hayrettin Tumani
JournalNeuroscience letters (Neurosci Lett) Vol. 657 Pg. 166-170 (Sep 14 2017) ISSN: 1872-7972 [Electronic] Ireland
PMID28802830 (Publication Type: Journal Article)
CopyrightCopyright © 2017 Elsevier B.V. All rights reserved.
Chemical References
  • Biomarkers
  • Glial Fibrillary Acidic Protein
Topics
  • Adolescent
  • Adult
  • Biomarkers (cerebrospinal fluid)
  • Brain (diagnostic imaging)
  • Female
  • Glial Fibrillary Acidic Protein (cerebrospinal fluid)
  • Humans
  • Inflammation (cerebrospinal fluid)
  • Male
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting (cerebrospinal fluid, diagnostic imaging)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: